NCT 06960395 Brief Summary This Phase 1, first-in-human (FIH), dose-escalation and dose-expansion…
Read more arrow_forwardNCT 04450732 Brief Summary Phase I Dose Finding Study for GQ1001 in…
Read more arrow_forwardACTRN 12623001216606 Brief Summary The purpose of the study is to investigate…
Read more arrow_forwardNCT 06736704 Brief Summary This study is testing a new medicine, SNV4818,…
Read more arrow_forwardACTRN 12622000495729 Brief Summary The purpose of this study is to compare…
Read more arrow_forwardNCT 05614258 Brief Summary ADG206 is an activatable prodrug form of a…
Read more arrow_forwardNCT 05267626 Brief Summary This is a first in human, open-label, multi-center…
Read more arrow_forwardNCT 06819735 Brief Summary This is a phase 1/2, dose-escalation and cohort-expansion…
Read more arrow_forwardNCT 03947385 Brief Summary This is a Phase 1/2, multi-center, open-label basket…
Read more arrow_forwardNCT 07156136 Brief Summary Phase 1 First-in-human study of the safety and…
Read more arrow_forward